发明名称 CARBAMOYL TETRAHYDROPYRIDINE DERIVATIVES
摘要 Carbamoyl tetrahydropyridine derivatives represented by general formula (1) and being efficacious against CRF-related diseases; medicinally acceptable salts of the same; and intermediates for the preparation thereof, wherein R<1> and R<2> are each independently hydrogen, C1-C5 alkyl, or the like; Y<1>-Y<2> is (R<4>)C=C(R<5>), (R<6>)C=N, N=N, (R<7>)N-CO, or N=C(R<8>); X<1>, X<2> and X<3> are each independently hydrogen, halogeno, or the like; R<3>, R<4>, R<5> and R<6> are each independently hydrogen or alkyl; R<7> is hydrogen, C1-C5 alkyl, or the like; and R<8> is hydrogen or carbamoyl.
申请公布号 WO0053604(A1) 申请公布日期 2000.09.14
申请号 WO2000JP01468 申请日期 2000.03.10
申请人 TAISHO PHARMACEUTICAL CO., LTD.;NAKAZATO, ATSURO;OKUBO, TAKETOSHI;KUMAGAI, TOSHIHITO;TOMISAWA, KAZUYUKI 发明人 NAKAZATO, ATSURO;OKUBO, TAKETOSHI;KUMAGAI, TOSHIHITO;TOMISAWA, KAZUYUKI
分类号 A61K31/519;A61P1/00;A61P7/10;A61P9/10;A61P9/12;A61P17/02;A61P25/08;A61P25/16;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P29/00;A61P37/02;A61P43/00;C07D473/00;C07D487/04;(IPC1-7):C07D473/34;C07D211/78;C07D207/34;A61K31/52 主分类号 A61K31/519
代理机构 代理人
主权项
地址